The impact of invisible-spreaders on COVID-19 transmission and work resumption

The global impact of coronavirus disease 2019 (COVID-19) is unprecedented, and many control and prevention measures have been implemented to test for and trace COVID-19. However, invisible-spreaders, who are associated with nucleic acid detection and asymptomatic infections, have received insufficie...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2022-01, Vol.17 (1), p.e0252994-e0252994
Main Authors: Wu, Chao, Xu, Cong, Mao, Feng, Xu, Xiaolin, Zhang, Chan
Format: Article
Language:English
Subjects:
Acids
Analysis
Asymptomatic
Asymptomatic Infections - epidemiology
Big Data
Biology and Life Sciences
Brazil - epidemiology
Coronaviruses
COVID-19
COVID-19 - diagnosis
COVID-19 - epidemiology
COVID-19 - transmission
COVID-19 - virology
Data science
Disease transmission
Epidemics
Experiments
Germany - epidemiology
Humans
India - epidemiology
Infections
Italy - epidemiology
Medical research
Medicine and Health Sciences
Models, Theoretical
Nucleic acids
Outbreaks
Pandemics
People and places
Quarantine
SARS-CoV-2 - isolation & purification
Spreaders
Sweden - epidemiology
Time series
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c692t-ea38ce92f97ec37193d5be2ad0e958fd0ca4921d8a771b34961b417314486b7a3
cites cdi_FETCH-LOGICAL-c692t-ea38ce92f97ec37193d5be2ad0e958fd0ca4921d8a771b34961b417314486b7a3
container_end_page e0252994
container_issue 1
container_start_page e0252994
container_title PloS one
container_volume 17
creator Wu, Chao
Xu, Cong
Mao, Feng
Xu, Xiaolin
Zhang, Chan
description The global impact of coronavirus disease 2019 (COVID-19) is unprecedented, and many control and prevention measures have been implemented to test for and trace COVID-19. However, invisible-spreaders, who are associated with nucleic acid detection and asymptomatic infections, have received insufficient attention in the current COVID-19 control efforts. In this paper, we analyze the time series infection data for Italy, Germany, Brazil, India and Sweden since the first wave outbreak to address the following issues through a series of experiments. We conclude that: 1) As of June 1, 2020, the proportion of invisible-spreaders is close to 0.4% in Sweden, 0.8% in early Italy and Germany, and 0.4% in the middle and late stages. However, in Brazil and India, the proportion still shows a gradual upward trend; 2) During the spread of this pandemic, even a slight increase in the proportion of invisible-spreaders could have large implications for the health of the community; and 3) On resuming work, the pandemic intervention measures will be relaxed, and invisible-spreaders will cause a new round of outbreaks.
doi_str_mv 10.1371/journal.pone.0252994
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2619172822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689350617</galeid><doaj_id>oai_doaj_org_article_2680d579900d416b95122de6824af4aa</doaj_id><sourcerecordid>A689350617</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-ea38ce92f97ec37193d5be2ad0e958fd0ca4921d8a771b34961b417314486b7a3</originalsourceid><addsrcrecordid>eNqNkl2L1DAUhoso7jr6D0QLguhFx3y3uRGW8WtgcUHXvQ1pczqTsW1q0q7678043WUqeyG9aDl9znty3rxJ8hSjJaY5frNzo-90s-xdB0tEOJGS3UtOsaQkEwTR-0ffJ8mjEHYIcVoI8TA5oRwRlBNymny-3EJq215XQ-rq1HbXNtiygSz0HrQBH1LXpauLq_W7DMt08LoLrQ3BxqruTPrT-e-phzC2_RBrj5MHtW4CPJnei-Tbh_eXq0_Z-cXH9ersPKuEJEMGmhYVSFLLHKq4jKSGl0C0QSB5URtUaSYJNoXOc1xSJgUuGc4pZqwQZa7pInl-0O0bF9RkRVBEYIlzUhASifWBME7vVO9tq_1v5bRVfwvOb5T2g60aiF0FMjyXEiHDsCglx4QYEAVhumZ6P-3tNG0sWzAVdNGHZiY6_9PZrdq4a1XknFHKo8CrScC7HyOEQUUPK2ga3YEbD-fmjAsiIvriH_Tu7SZqo-MCtqtdnFvtRdWZKGS8XxHtWiTLO6j4GGhtFXNT21ifNbyeNURmgF_DRo8hqPXXL__PXlzN2ZdH7BZ0M2yDa8Z9ZMIcZAew8i4ED_WtyRipfexv3FD72Ksp9rHt2fEF3Tbd5Jz-ASyq-vo</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2619172822</pqid></control><display><type>article</type><title>The impact of invisible-spreaders on COVID-19 transmission and work resumption</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Wu, Chao ; Xu, Cong ; Mao, Feng ; Xu, Xiaolin ; Zhang, Chan</creator><contributor>Hernandez-Vargas, Esteban</contributor><creatorcontrib>Wu, Chao ; Xu, Cong ; Mao, Feng ; Xu, Xiaolin ; Zhang, Chan ; Hernandez-Vargas, Esteban</creatorcontrib><description>The global impact of coronavirus disease 2019 (COVID-19) is unprecedented, and many control and prevention measures have been implemented to test for and trace COVID-19. However, invisible-spreaders, who are associated with nucleic acid detection and asymptomatic infections, have received insufficient attention in the current COVID-19 control efforts. In this paper, we analyze the time series infection data for Italy, Germany, Brazil, India and Sweden since the first wave outbreak to address the following issues through a series of experiments. We conclude that: 1) As of June 1, 2020, the proportion of invisible-spreaders is close to 0.4% in Sweden, 0.8% in early Italy and Germany, and 0.4% in the middle and late stages. However, in Brazil and India, the proportion still shows a gradual upward trend; 2) During the spread of this pandemic, even a slight increase in the proportion of invisible-spreaders could have large implications for the health of the community; and 3) On resuming work, the pandemic intervention measures will be relaxed, and invisible-spreaders will cause a new round of outbreaks.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0252994</identifier><identifier>PMID: 35020722</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acids ; Analysis ; Asymptomatic ; Asymptomatic Infections - epidemiology ; Big Data ; Biology and Life Sciences ; Brazil - epidemiology ; Coronaviruses ; COVID-19 ; COVID-19 - diagnosis ; COVID-19 - epidemiology ; COVID-19 - transmission ; COVID-19 - virology ; Data science ; Disease transmission ; Epidemics ; Experiments ; Germany - epidemiology ; Humans ; India - epidemiology ; Infections ; Italy - epidemiology ; Medical research ; Medicine and Health Sciences ; Models, Theoretical ; Nucleic acids ; Outbreaks ; Pandemics ; People and places ; Quarantine ; SARS-CoV-2 - isolation &amp; purification ; Spreaders ; Sweden - epidemiology ; Time series ; Viral diseases</subject><ispartof>PloS one, 2022-01, Vol.17 (1), p.e0252994-e0252994</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><rights>2022 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Wu et al 2022 Wu et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-ea38ce92f97ec37193d5be2ad0e958fd0ca4921d8a771b34961b417314486b7a3</citedby><cites>FETCH-LOGICAL-c692t-ea38ce92f97ec37193d5be2ad0e958fd0ca4921d8a771b34961b417314486b7a3</cites><orcidid>0000-0002-8203-9878 ; 0000-0002-1024-408X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2619172822/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2619172822?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35020722$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Hernandez-Vargas, Esteban</contributor><creatorcontrib>Wu, Chao</creatorcontrib><creatorcontrib>Xu, Cong</creatorcontrib><creatorcontrib>Mao, Feng</creatorcontrib><creatorcontrib>Xu, Xiaolin</creatorcontrib><creatorcontrib>Zhang, Chan</creatorcontrib><title>The impact of invisible-spreaders on COVID-19 transmission and work resumption</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The global impact of coronavirus disease 2019 (COVID-19) is unprecedented, and many control and prevention measures have been implemented to test for and trace COVID-19. However, invisible-spreaders, who are associated with nucleic acid detection and asymptomatic infections, have received insufficient attention in the current COVID-19 control efforts. In this paper, we analyze the time series infection data for Italy, Germany, Brazil, India and Sweden since the first wave outbreak to address the following issues through a series of experiments. We conclude that: 1) As of June 1, 2020, the proportion of invisible-spreaders is close to 0.4% in Sweden, 0.8% in early Italy and Germany, and 0.4% in the middle and late stages. However, in Brazil and India, the proportion still shows a gradual upward trend; 2) During the spread of this pandemic, even a slight increase in the proportion of invisible-spreaders could have large implications for the health of the community; and 3) On resuming work, the pandemic intervention measures will be relaxed, and invisible-spreaders will cause a new round of outbreaks.</description><subject>Acids</subject><subject>Analysis</subject><subject>Asymptomatic</subject><subject>Asymptomatic Infections - epidemiology</subject><subject>Big Data</subject><subject>Biology and Life Sciences</subject><subject>Brazil - epidemiology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - transmission</subject><subject>COVID-19 - virology</subject><subject>Data science</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>Experiments</subject><subject>Germany - epidemiology</subject><subject>Humans</subject><subject>India - epidemiology</subject><subject>Infections</subject><subject>Italy - epidemiology</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Models, Theoretical</subject><subject>Nucleic acids</subject><subject>Outbreaks</subject><subject>Pandemics</subject><subject>People and places</subject><subject>Quarantine</subject><subject>SARS-CoV-2 - isolation &amp; purification</subject><subject>Spreaders</subject><subject>Sweden - epidemiology</subject><subject>Time series</subject><subject>Viral diseases</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2L1DAUhoso7jr6D0QLguhFx3y3uRGW8WtgcUHXvQ1pczqTsW1q0q7678043WUqeyG9aDl9znty3rxJ8hSjJaY5frNzo-90s-xdB0tEOJGS3UtOsaQkEwTR-0ffJ8mjEHYIcVoI8TA5oRwRlBNymny-3EJq215XQ-rq1HbXNtiygSz0HrQBH1LXpauLq_W7DMt08LoLrQ3BxqruTPrT-e-phzC2_RBrj5MHtW4CPJnei-Tbh_eXq0_Z-cXH9ersPKuEJEMGmhYVSFLLHKq4jKSGl0C0QSB5URtUaSYJNoXOc1xSJgUuGc4pZqwQZa7pInl-0O0bF9RkRVBEYIlzUhASifWBME7vVO9tq_1v5bRVfwvOb5T2g60aiF0FMjyXEiHDsCglx4QYEAVhumZ6P-3tNG0sWzAVdNGHZiY6_9PZrdq4a1XknFHKo8CrScC7HyOEQUUPK2ga3YEbD-fmjAsiIvriH_Tu7SZqo-MCtqtdnFvtRdWZKGS8XxHtWiTLO6j4GGhtFXNT21ifNbyeNURmgF_DRo8hqPXXL__PXlzN2ZdH7BZ0M2yDa8Z9ZMIcZAew8i4ED_WtyRipfexv3FD72Ksp9rHt2fEF3Tbd5Jz-ASyq-vo</recordid><startdate>20220112</startdate><enddate>20220112</enddate><creator>Wu, Chao</creator><creator>Xu, Cong</creator><creator>Mao, Feng</creator><creator>Xu, Xiaolin</creator><creator>Zhang, Chan</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8203-9878</orcidid><orcidid>https://orcid.org/0000-0002-1024-408X</orcidid></search><sort><creationdate>20220112</creationdate><title>The impact of invisible-spreaders on COVID-19 transmission and work resumption</title><author>Wu, Chao ; Xu, Cong ; Mao, Feng ; Xu, Xiaolin ; Zhang, Chan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-ea38ce92f97ec37193d5be2ad0e958fd0ca4921d8a771b34961b417314486b7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acids</topic><topic>Analysis</topic><topic>Asymptomatic</topic><topic>Asymptomatic Infections - epidemiology</topic><topic>Big Data</topic><topic>Biology and Life Sciences</topic><topic>Brazil - epidemiology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - transmission</topic><topic>COVID-19 - virology</topic><topic>Data science</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>Experiments</topic><topic>Germany - epidemiology</topic><topic>Humans</topic><topic>India - epidemiology</topic><topic>Infections</topic><topic>Italy - epidemiology</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Models, Theoretical</topic><topic>Nucleic acids</topic><topic>Outbreaks</topic><topic>Pandemics</topic><topic>People and places</topic><topic>Quarantine</topic><topic>SARS-CoV-2 - isolation &amp; purification</topic><topic>Spreaders</topic><topic>Sweden - epidemiology</topic><topic>Time series</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Chao</creatorcontrib><creatorcontrib>Xu, Cong</creatorcontrib><creatorcontrib>Mao, Feng</creatorcontrib><creatorcontrib>Xu, Xiaolin</creatorcontrib><creatorcontrib>Zhang, Chan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Chao</au><au>Xu, Cong</au><au>Mao, Feng</au><au>Xu, Xiaolin</au><au>Zhang, Chan</au><au>Hernandez-Vargas, Esteban</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of invisible-spreaders on COVID-19 transmission and work resumption</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2022-01-12</date><risdate>2022</risdate><volume>17</volume><issue>1</issue><spage>e0252994</spage><epage>e0252994</epage><pages>e0252994-e0252994</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The global impact of coronavirus disease 2019 (COVID-19) is unprecedented, and many control and prevention measures have been implemented to test for and trace COVID-19. However, invisible-spreaders, who are associated with nucleic acid detection and asymptomatic infections, have received insufficient attention in the current COVID-19 control efforts. In this paper, we analyze the time series infection data for Italy, Germany, Brazil, India and Sweden since the first wave outbreak to address the following issues through a series of experiments. We conclude that: 1) As of June 1, 2020, the proportion of invisible-spreaders is close to 0.4% in Sweden, 0.8% in early Italy and Germany, and 0.4% in the middle and late stages. However, in Brazil and India, the proportion still shows a gradual upward trend; 2) During the spread of this pandemic, even a slight increase in the proportion of invisible-spreaders could have large implications for the health of the community; and 3) On resuming work, the pandemic intervention measures will be relaxed, and invisible-spreaders will cause a new round of outbreaks.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>35020722</pmid><doi>10.1371/journal.pone.0252994</doi><tpages>e0252994</tpages><orcidid>https://orcid.org/0000-0002-8203-9878</orcidid><orcidid>https://orcid.org/0000-0002-1024-408X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2022-01, Vol.17 (1), p.e0252994-e0252994
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2619172822
source ProQuest - Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Acids
Analysis
Asymptomatic
Asymptomatic Infections - epidemiology
Big Data
Biology and Life Sciences
Brazil - epidemiology
Coronaviruses
COVID-19
COVID-19 - diagnosis
COVID-19 - epidemiology
COVID-19 - transmission
COVID-19 - virology
Data science
Disease transmission
Epidemics
Experiments
Germany - epidemiology
Humans
India - epidemiology
Infections
Italy - epidemiology
Medical research
Medicine and Health Sciences
Models, Theoretical
Nucleic acids
Outbreaks
Pandemics
People and places
Quarantine
SARS-CoV-2 - isolation & purification
Spreaders
Sweden - epidemiology
Time series
Viral diseases
title The impact of invisible-spreaders on COVID-19 transmission and work resumption
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A40%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20invisible-spreaders%20on%20COVID-19%20transmission%20and%20work%20resumption&rft.jtitle=PloS%20one&rft.au=Wu,%20Chao&rft.date=2022-01-12&rft.volume=17&rft.issue=1&rft.spage=e0252994&rft.epage=e0252994&rft.pages=e0252994-e0252994&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0252994&rft_dat=%3Cgale_plos_%3EA689350617%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-ea38ce92f97ec37193d5be2ad0e958fd0ca4921d8a771b34961b417314486b7a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2619172822&rft_id=info:pmid/35020722&rft_galeid=A689350617&rfr_iscdi=true